A high-performing workforce starts with mental health. Lyra is your partner in delivering evidence-based mental health care that transforms lives and drives business results.

Worldwide, 970 million people are living with mental health issues. The biggest hurdle isn’t treatment—it’s access. Lyra’s co-founder and CEO, David Ebersman, left his job as Meta’s chief financial officer in 2014 to tackle the problem by making it easier to find and get treatment and using technology to make it smarter, more personalized, and more effective.

Since then, more than 300 leading companies have partnered to offer Lyra’s mental health benefits to their employees, including Meta, Pinterest, and Starbucks, giving more than 13 million people access to life-changing care.

With Lyra 88% of members improve or recover. Lyra uses validated clinical measures, such as the PHQ-9 and the GAD-7, to assess symptom improvement for anxiety, depression, and other common mental health issues. Reliable clinical change is a 6-point difference on the PHQ-9 and a 4-point change on the GAD-7.

At Lyra, we use “reliable clinical improvement” to measure change, which means that an individual in treatment has improved enough on a measure of clinical symptoms that we don’t believe the change can be accounted for by normal variation in scores or measurement error.

It's critical for organizations to understand and quantify the impact of the social determinants of health (SDOH) affecting their populations to reduce exorbitant costs and poor health outcomes. SocialScape®, our Social Risk IntelligenceTM platform and advisory team illuminate where social risk exists, why it matters, and what to do about it for maximum business and community impact.